Controversial Alzheimer's drug gets limited approval from Medicare
While Medicare has "approved" Biogen's Alzheimer's drug Aduhelm, the agency has put strict limits on the drug, only allowing its use for patients during clinical trials. |!| Sidney
While Medicare has "approved" Biogen's Alzheimer's drug Aduhelm, the agency has put strict limits on the drug, only allowing its use for patients during clinical trials. |!| Sidney